Author(s): Raj K. Prasad, Kavita R. Loksh

Email(s): rajdavv2007@gmail.com

DOI: 10.52711/2231-5713.2022.00060   

Address: Raj K. Prasad*, Kavita R. Loksh
Department of Pharmacy, Oriental University, Indore, Madhya Pradesh – 453555.
*Corresponding Author

Published In:   Volume - 12,      Issue - 4,     Year - 2022


ABSTRACT:
Cancer can conquer or feast on nearly all portions of the body. The cumulative illness and high humanity of cancer generate an innumerable claims for the expansion of innovative anticancer drugs. Coumarin (known as 1,2-benzopyrone or o-hydroxycinnamic acid-8-lactone) encompasses a huge class of phenolic offshoots that originate in plants and they are entailed of bonded benzene and a-pyrone rings. Numerous studies have exposed that several substituents on the coumarin essential structure stimulus different biological activities. Coumarin advert a character of pathways in cancer like kinase inhibition, cell cycle annexation, angiogenesis inhibition, telomerase inhibition, antimitotic activity, carbonic anhydrase inhibition, monocarboxylate transporters inhibition, aromatase inhibition, and sulfatase inhibition. Coumarin moiety is a beneficial template for the progress of novel anticancer agents.


Cite this article:
Raj K. Prasad, Kavita R. Loksh. Anticancer Potential of Coumarin derivatives: A Review. Asian Journal of Pharmacy and Technology; 12(4):391-0. doi: 10.52711/2231-5713.2022.00060

Cite(Electronic):
Raj K. Prasad, Kavita R. Loksh. Anticancer Potential of Coumarin derivatives: A Review. Asian Journal of Pharmacy and Technology; 12(4):391-0. doi: 10.52711/2231-5713.2022.00060   Available on: https://ajptonline.com/AbstractView.aspx?PID=2022-12-4-15


REFERENCES:
1.    Chia-Hsiung C, Ku-Chung L, Wai-Theng W, Yen-Fang X, Lin. C. Induction of ROS-independent JNK-activation-mediated apoptosis by a novel coumarin derivative, DMAC, in human colon cancer cells. Chem. Bio. Int. 2014; 218:42-49.
2.    Saidu N, Valente S, Emilie B, Gilbert K, Denyse B, Mathias M. Coumarin polysulfides inhibit cell growth and induce apoptosis in HCT116 colon cancer cells. Biog. Med. Chem. 2012; 4:1584-1593.
3.    Anees A, Pangal, JA, Shaikh Ejazuddin MK. Current Developments of C3-Substituted Coumarin Hybrids as Anti-Cancer Agents. Int. J. Pharm. Sci. Rev. Res. 2017; 42(1):161-168.
4.    Jain PK, Himanshu J. Coumarin: Chemical and Pharmacological Profile. Journal of Applied Pharmaceutical Science, 2012; 2(6):236-240.
5.    Douglas H, Gabriele B, Emily B. Metronomic dosing of cytotoxic drugs can target tumor angiogenesis in mice. J Clin Invest. 2000; 105(8):1045–1047.
6.    Christos K, Anastasia D, Dimitra HL. Expert Opin. Ther. Patents. 2012; 22(4).
7.    Aoife L, Richard O. Studies on Coumarins and Coumarin-Related Compounds to Determine their Therapeutic Role in the Treatment of Cancer. CurrentPharmaceutical Design. 2004; 10:3797-3811.
8.    Murray RDH, Mendez J, Brown RA. The Natural Coumarins. J. Wiley and Sons; New York: 1982.
9.    Xin-Mei P, Guri LVD, Cheng HZ, Current Developments of Coumarin Compounds in Medicinal Chemistry. Curr. Pharm. Des.2013; 19:3884-3930.
10.    Murray RDH, Herz W, Kirby GW, Steglich W, Tamm C.  Progress in the chemistry of organic natural products In Coumarins. Springer-Verlag.1991; 8:84-316.
11.    Gummudavelly S, Ranganath YS, Bhasker S, Rajkumar N. Synthesis and Biological Screening of Some Novel, Coumarin Derivatives, Asian J. Research Chem. 2009; 2(1):46-48.
12.    Mirunalini S, Krishnaveni M, Coumarin: A Plant-derived Polyphenol with wide Biomedical Applications, International Journal of PharmTech Research. 2011; 3(3): 1693-1696.
13.    Fesser G and Ellis GH. The metabolism and biological actions of coumarins in West, Progress in medicinal chemistry, North-Holland Publishing Company, Amsterdam 1974; 5:158.
14.    Muray RD. Progress in the chemistry of organic natural products. In naturally occurring plant coumarins. 1991; 58:83-316.
15.    Gummudavelly S, Ranganath Y, Bhasker S, Rajkumar N. Synthesis and biological screening of some novel coumarin derivatives. Asian Journal of Research in Chemistry. 2009;2(1):46-8.
16.    Soman SS, Thaker TH, Baloni RD. Synthesis of Amino acetyl coumarins and Amino acetyl naphtho-coumarins and their Antibacterial activity study. Asian Journal of Research in Chemistry. 2011;4(1):132-6.
17.    Prabha I, Nagarajan NS. Synthesis, anti-larvicidal and anti-bacterial studies of 7-hydroxy-4methylcoumarin, 7-acetoxy-4-methyl coumarin, 8-acetyl-7-hydroxy-4methylcoumarin, resacetophenone, 8-acetyl-5-hydroxy-4-methylcoumarin and 4, 7-dimethylcoumarin. Research Journal of Pharmacy and Technology. 2016;9(4):423-9.
18.    Kavitha K, Sree BK, Preethi JP, Kumar PK, Rajvel R, Sivakumar T. Synthesis, Characterization and Biological Activity of Coumarin Derivatives. Research Journal of Science and Technology. 2012; 1;4(6):II.
19.    Jelena K, Maja M. Natural and synthetic coumarins as potential anticancer agents, J. Chem. Pharm. Res., 2015; 7(7):1223-1238.
20.    Jurgen G, Hironobu S, Shiuan C, Atul P. Steroid sulfatase inhibitors: Promising new tools for breast cancer therapy. J. Steroid Biochem. Mol. Bio., 2011; 125:39-45.
21.    Matos MJ, Rodriguez SV, Santana L, Uriarte E, Edfuf CF, Santos Y, Munoz-Crego A.Looking for new targets: simple coumarins as antibacterial agents.Med. Chem. 2012; 8:1140-1146.
22.    Shi Y, Zhou CH.Synthesis and evaluation of a class of new coumarin triazole derivatives as potential antimicrobial agents. Bioorg. Med. Chem. Lett. 2011; 21: 956-961.
23.    Nargotra S, Sharma MI, Alam Z, Ahmed A, Bhagat SC, Taneja GN, Koul QS.In silico identification of viper phospholipaseA2 inhibitors: validation by in vitro, in vivo studies. J. Mol. Model. 2011; 17:3063-3068.
24.    Bhattacharya S. Natural antimutagens: A review. J. Med. Plants. Res. 2011; 5:116-121.
25.    Bhat KI, Apoorva A, Kumar A, Kumar P. Synthesis and Antioxidant Activity of Some New Coumarin Incorporated 4-Thiazolidinone Derivatives. Research Journal of Pharmacy and Technology. 2018;11(12):5408-12.
26.    Naasani N, Harbali J, Kandil F. Synthesis and Biological Evaluation of 3-thiosemicarbazoneacetyl Coumarin derivatives as Antioxidant. Research Journal of Pharmacy and Technology. 2020; 13(10):4565-9.
27.    Joshi H, Singh B, Saxena GK, Singh V, Singhand RP, Arya. Synthesis and characterization of novel halogens substituted coumarin-Aldehyde. Int. J. Chem. Pharm. Sci. 2012; 4:19-24.
28.    Patel RM, Patel JN. In vitro cytotoxic screening of 4-Methyl-2h-Chromen-2-One derivatives against Hep2 cell line.J. Adv. Pharm. Technol. Res. 2011; 1:52-58.
29.    Swarnakar NK, Jain AK, Singh RP, Godugu C, Das M, Jain S. Oral bioavailability, therapeutic efficacy and reactive oxygen species scavenging properties of coenzyme Q10-loaded polymeric nanoparticles. Biomaterials. 2011; 32:6860-6866.
30.    Bansal Y, Sethi P, Bansal G. Coumarin: a potential nucleus for anti-inflammatory molecules. Med. Chem. Res. 2013; 22:3049-3060.
31.    Jain PK, Joshi H. Coumarin: Chemical and Pharmacological Profile. Journal of Applied Pharmaceutical Science. 2012; 2(6):236-240.
32.    Manjunatha M, Naik VH, Kulkarni AD, Patil SA. DNA cleavage, antimicrobial, anti-inflammatory anthelmintic activities, and spectroscopic studies of Co (II), Ni (II), and Cu (II) complexes of biologically potential coumarin Schiff bases. J. Coord. Chem. 2011; 64:4264-4271.
33.    Watzka M, Geisen C, Bevans C, Sittinger K, Spohn G, Rost S, Seifried E, Müller C, Oldenburg DJ. Thirteen novel VKORC1 mutations associated with oral anticoagulant resistance: insights into improved patient diagnosis and treatment. J. Thromb. Haemost. 2011; 9:109-118.
34.    Weigt S, Huebler N, Strecker R, Braunbeck T, Broschard T.H. Developmental effects of coumarin and the anticoagulant coumarin derivative warfarin on zebrafish Danio rerio embryos. Reprod. Toxicol. 2012; 33:133-138.
35.    Kwon OS, Choi JS, Islam MN, Kim YS, Kim HP. Inhibition of 5-lipoxygenase and skin inflammation by the aerial parts of Artemisia capillaries and its constituents. Arch. Pharm. Res. 2011; 34:1561-1566.
36.    Murat BH, Atmaca M, Deniz OB, Özekinci BS, Taşdemir E, Ketani A.Protective effects of coumarin and coumarin derivatives against carbon tetrachloride-induced acute hepatotoxicity in rats. Exp. Toxicol. Pathol, 2011; 63:325-331.
37.    Bhat KI, Apoorva A, Kumar A, Kumar P. Synthesis and Antidiabetic Evaluation of Some New Coumarin Coupled 4-Thiazolidinone Derivatives. Research Journal of Pharmacy and Technology. 2019;12(11):5215-8.
38.    Shah VV, Doijad RC, Shah NV. Microwave-assisted synthesis of novel Coumarin derivatives for its Anti-Inflammatory applications. Research Journal of Pharmacy and Technology. 2020;13(6):2906-11.
39.    Mendes FR, Negri G, Duarte-Almeida JM, Tabach R, Carlini A. Plant Bioactives and Drug Discovery: Principles, Practice, and Perspectives. Wiley. 2012; 17:161-166.
40.    Amin. KM, Abdel Gawad NM, Abdel Rahman DE, El Ashry MK. Design, synthesis, and vasorelaxant evaluation of novel coumarin–pyrimidine hybrids. Bioorg. Chem. 2014; 52:31-36.
41.    ChamandeepKB, Amandeep K. Synthesis and Spectral Studies of Novel 3-(5-mercapto-1, 3, 4-oxadiazol-2-yl)-2H-chromen-2-one Derivatives as Anticancer Agents. Int. J. Chem, Pharm, Sci. 2015; 3(10):2006-2023.
42.    Jain M, Surin WR, Misra A, Prakash P, Singh V, Khanna V, Kumar S, Siddiqui HH, Raj K, Barthwal MK. Antithrombotic Activity of a Newly Synthesized Coumarin Derivative 3‐(5‐Hydroxy‐2, 2‐dimethyl‐chroman‐6‐yl)‐N‐{2‐[3‐(5‐hydroxy‐2,2‐dimethyl‐chroman‐6‐yl)-propionylamino]‐ethyl}‐propionamide. Chem. Biol. Drug Des. 2013; 81:499-505.
43.    Bae YH, Park K. Targeted drug delivery to tumors: myths, reality, and possibility. J Control Release. 2011; 153(3):198–205; doi:10.1016/j. jconrel.2011.06.001.
44.    Amin KM, Awadalla FM, Eissa AA, Abou Seri SM, Hassan GS. Design, synthesis, and vasorelaxant evaluation of novel coumarin–pyrimidine hybrids. Bioorg. Med. Chem. 2011; 19:6087-6092.
45.    Bertin R, Chen Z, Martínez-Vázquez M, García-Argaéz A, Froldi G. Vasodilation and radical-scavenging activity of imperatorin and selected coumarinic and flavonoid compounds from genus Casimiroa. Phytomedicine. 2014; 21:586-592.
46.    Mohit S, Gupta J, Tarun V. Recent advancements in Uracil and 5-Fluorouracil hybrids as potential anticancer agents: A review Journal of Applied Pharmaceutical Science., 2020; 10(02):129-146.
47.    Holiyachi M. et al. Design, synthesis and structure-activity relationship study of coumarin benzimidazole hybrid as potent antibacterial and anticancer agents. Chemistry Select. 2016; 1:4638–4644.
48.    Basanagouda M, Vishwanath B, Barigidad N, Laxmeshwar S, Devaru S, Venkatesh N. Synthesis, the structure-activity relationship of iodinated-4-aryloxy methyl coumarins as potential anti-cancer and anti-mycobacterial agents. Eur. J. Med. Chem. 2014; 74:225-233.
49.    Mazzone G, Naim M, Galano A, Russoa N, Toscano M. Antioxidant properties of several coumarins–chalcone hybrids from theoretical insights.  RSC Adv. 2015; 5:565.
50.    Peng XM, Damu GLV, Zhou C.-H. Current developments of coumarin compounds in medicinal chemistry. Current Pharmaceutical Design. 2013; 19(21):3884–3930.
51.    Abdizadeh T, Kalani MR, Abnous K. Design, synthesis and biological evaluation of novel coumarin-based benzamides as potent histone deacetylase inhibitors and anticancer agents. Eur. J. Med. Chem. 2017; 132:42–62.
52.    Nasra T, Samir B, Mahmoud Y. Anticancer activity of new coumarin substituted hydrazide–hydrazone derivatives. European Journal of Medicinal Chemistry. 2014; 76(9):539-548.
53.    Koneni VS, Abdhesh K, Manoj K, Jayanta S, Sudhir S. Synthesis and in vitro evaluation of novel coumarin–chalcone hybrids as potential anticancer agents. 2015; 35:653-659.
54.    Venugopala KN, Rashmi V, Odhav B. Review on natural coumarin lead compounds for their pharmacological activity. BioMed Research International. 2013; Article ID 963248, 14.
55.    Lamya H. Wahaib A, Hanaa MAM, Diaa AI. Synthesis of Novel 1,2,4-Triazolyl Coumarin Derivatives as Potential Anticancer Agents. Hindawi Journal of Chemistry. 2018; 1-8.
56.    Dandriyal J, Singla R, Kumar M, Jaitak V. Recent developments of C-4 substituted coumarin derivatives as anticancer agents. European Journal of Medicinal Chemistry.2016; DOI: 10.1016/j.ejmech.2016.03.087.
57.    Musa MA, Joseph MY, Latinwo LM, Badisa V, Cooperwood JS. Anticancer Res. 2015; 35(2):653-659.
58.    Mert O¸ Tekin SS, Bülent A, Süleyman S. Cytotoxic effects of coumarin substituted benzimidazolium salts against human prostate and ovarian cancer cells. J. Chem. Sci.2019; 131:69.
59.    Lee HY, Tsai AC, Chen MC, Shen PJ, Cheng YC, Kuo CC, Pan SL, Liu YM, Liu JF, Yeh TK, Wang JC, Chang CY, Chang JY, Liou JP. Azaindolylsulfonamides with a more selective inhibitory effect on histone deacetylase-6 activity, exhibit antitumor activity in colorectal cancer HCT116 cells. J. Med. Chem. 2017; 57:4009-4022.
60.    Sashidhara KV, Kumar A, Dodda RP, Krishna NN, Agarwal P, Srivastava K, Puri SK. Bioorg. Med. Chem. Lett. 2016; 22:3926-3930.
61.    Yubin W, Haitao L, Peng L, Rui M, Xiaojian X, Chen F, JinXiong S.Design, synthesis and in vitro evaluation of novel 3, 7-disubstituted coumarin derivatives as potent anticancer agents. DOI: 10.1111/cbdd.12531.
62.    Mazaahir K, Roona P, Arti J, Rakesh K, Pratibha ML.Synthesis and SARs of Coumarin Fused 1, 5-Benzothiazepines as Novel Anticancer and Antioxidant Agents. Mini-Reviews in Organic Chemistry. 2015; 12:24-33.
63.    Gurrapu S, Jonnalagadda SK, Alam M.A, Ronayne CT, Nelson GL, Solano LN, Lueth EA, Drewes LR, Mereddy VR. Coumarin carboxylic acids as monocarboxylate transporter 1 inhibitors: In vitro and in vivo studies as potential anticancer agents, Bioorganic and Medicinal Chemistry Letters. 2016; DOI: http://dx.doi.org/10.1016/j.bmcl.2016.05.054.
64.    Sumathi V, Bhavani AKD. Synthesis of novel quinazolinone-coumarins as anticancer agents. Biochem&Pharmacol, 2013; 2:4.
65.    Hany A, El-Sherief, Gamal El-DA, Abuo R, Mai ES, Eman AB, Rehab MA. Design and synthesis of new coumarin–chalcone/NO hybrids of potential biological activity. DOI 10.1007/s00044-017-2004-9.
66.    Zhi X, Shi-Jia Z, Jia-Lun D, Qin W, Zao-Sheng L, Yi-Lei F. Design, Synthesis, and Evaluation of Tetraethylene Glycol Tethered Isatin–Coumarin Hybrids as Novel Anticancer Agents. J. Heterocyclic Chem.2018; DOI: 10.1002/jhet.3411.
67.    Sobhi MG, Hassan MA, Ahmed AM El-Reedy F. Synthesis of Pyrazolo[3,4-c] pyrazoles Bearing Coumarine Ring as Anticancer Agents. J. Heterocyclic Chem.2018; DOI: 10.1002/jhet.3235.
68.    Lingaraju GS, Balaji KS, Jayarama S, Anil SM, Kiran KR, Sadashiva MP. Synthesis of New Coumarin Tethered Isoxazolines as Potential Anticancer Agents. Bioorganic and Medicinal Chemistry Letters. 2018; DOI: https://doi.org/10.1016/j.bmcl.2018.10.046.
69.    Nerella SG et al. Synthesis and Biological evaluation of morpholines linked coumarin-triazole hybrids as anticancer agents. chemical biology and drug design. 2019; 94(5): 1919-1929. DOI: 10.1111/cbdd.13578.
70.    Eman AF, Rehab S, Marwa FH, Ahmed BMM. Design, synthesis, biological evaluation, and molecular modeling of new coumarin derivatives as potent anticancer agents. Medicinal Chemistry Research. 2019; https://doi.org/10.1007/s00044-019-02373-x.
71.    Belma ZK, Nur Ozten K, Aydan D, Fatih S, Mustafa K. Synthesis and biological evaluation of novel coumarin-chalcone derivatives containing urea moiety as potential anticancer agents. Arabian Journal of Chemistry. 2020; 13:1120–1129, https://doi.org/10.1016/j.arabjc.2017.10.001.







Recomonded Articles:

Author(s): Hafsa, Asfa, Nuha Rasheed, Abdul Saleem Mohammad

DOI: 10.5958/2231-5713.2017.00001.0         Access: Open Access Read More

Author(s): Dibyajyoti Saha, Vibhor kumar Jain, Bindu Jain, Roshni Tandey

DOI:         Access: Open Access Read More

Author(s): Amit Roy, Pushpa Prasad, Nirmala Gupta

DOI:         Access: Open Access Read More

Author(s): A. K. Meena, Jyoti Meena, Ankush Jadhav, M. M. Padhi

DOI:         Access: Open Access Read More

Author(s): Beedha. Saraswathi, Dr. T. Satyanarayana, K. Mounika, G. Swathi , K. Sravika, M. Mohan Krishna

DOI: 10.5958/2231-5713.2018.00004.1         Access: Open Access Read More

Author(s): A. Elumalai, Nikhitha Mathangi, Adarsh Didala, Raju Kasarla, Yetcharla Venkatesh

DOI:         Access: Open Access Read More

Author(s): Chaudhari R. D, Girase P. R, Suryawanshi H. P, Pawar S. P

DOI: 10.5958/2231-5713.2018.00025.9         Access: Open Access Read More

Author(s): Kruti M. Patel, Pratik R. Patel

DOI: 10.5958/2231-5713.2017.00036.8         Access: Open Access Read More

Author(s): Himanshu Deshmkh, Chandrashekhara S., Nagesh C., Amol Murade, Shridhar Usgaunkar.

DOI:         Access: Open Access Read More

Author(s): Jangam Payal R, Thombre Nilima A, Gaikwad Pallavi N

DOI: 10.5958/2231-5713.2017.00027.7         Access: Open Access Read More

Author(s): Rajendra Jangde

DOI:         Access: Open Access Read More

Author(s): R.B. Saudagar, S. Samuel

DOI: 10.5958/2231-5713.2016.00019.2         Access: Open Access Read More

Author(s): Kanchan R. Pagar, Sarika V. Khandbahale

DOI: 10.5958/2231-5713.2019.00023.0         Access: Open Access Read More

Author(s): Dibyajyoti Saha, Tarashankar Maity, Mayukh Jana, Supradip Mandal

DOI:         Access: Open Access Read More

Author(s): Sarjavalagi Vishal Gopal, Prabhat Kumar Chaurasia, Harshitha Arun Pardhe, Singh Suryansh Santosh, Narayan Sah Sonar

DOI: 10.5958/2231-5713.2020.00046.X         Access: Open Access Read More

Author(s): Krushna K. Zambare, Avinash B. Thalkari, Nagesh S. Tour, Kavya V. Reddy

DOI: 10.5958/2231-5713.2019.00019.9         Access: Open Access Read More

Author(s): Jaya Preethi P., Karthikeyan E., Lohita M., Goutham Teja P., Subhash M., Shaheena P., Prashanth Y., Sai Nandhu K.

DOI: 10.5958/2231-5713.2015.00021.5         Access: Open Access Read More

Author(s): Selvakumar K., Madhan R., Srinivasan G. , Baskar V.

DOI:         Access: Open Access Read More

Author(s): S. Rawat, Akhilesh Gupta

DOI:         Access: Open Access Read More

Asian Journal of Pharmacy and Technology (AJPTech.) is an international, peer-reviewed journal, devoted to pharmaceutical sciences...... Read more >>>

RNI: Not Available                     
DOI: 10.5958/2231–5713 


Recent Articles




Tags